EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 73 filers reported holding EVELO BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,000 | -42.9% | 2,381 | 0.0% | 0.00% | – |
| Q4 2021 | $14,000 | -17.6% | 2,381 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $17,000 | -48.5% | 2,381 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $33,000 | +83.3% | 2,381 | +41.1% | 0.00% | 0.0% |
| Q1 2021 | $18,000 | +28.6% | 1,688 | +49.0% | 0.00% | 0.0% |
| Q4 2020 | $14,000 | +133.3% | 1,133 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | 0.0% | 1,133 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | +50.0% | 1,133 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | -20.0% | 1,133 | 0.0% | 0.00% | – |
| Q4 2019 | $5,000 | -28.6% | 1,133 | 0.0% | 0.00% | – |
| Q3 2019 | $7,000 | -30.0% | 1,133 | 0.0% | 0.00% | – |
| Q2 2019 | $10,000 | +11.1% | 1,133 | 0.0% | 0.00% | – |
| Q1 2019 | $9,000 | +80.0% | 1,133 | +203.8% | 0.00% | – |
| Q4 2018 | $5,000 | 0.0% | 373 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | +25.0% | 373 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | – | 373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 18,233,403 | $215,154,000 | 41.21% |
| HARBOURVEST PARTNERS LLC | 1,763,505 | $20,809,000 | 26.29% |
| Alphabet Inc. | 1,060,495 | $12,514,000 | 1.05% |
| SECTORAL ASSET MANAGEMENT INC | 437,500 | $5,163,000 | 0.58% |
| DC Investments Management, LLC | 36,924 | $436,000 | 0.28% |
| ARK Investment Management | 126,831 | $1,497,000 | 0.06% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 22,998 | $271,000 | 0.03% |
| Laurion Capital Management LP | 150,000 | $1,770,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 9,380 | $111,000 | 0.01% |
| CREDIT SUISSE AG/ | 440,169 | $5,194,000 | 0.01% |